National Institute of Allergy and Infectious Diseases (NIAID)

5601 Fishers Lane, MSC 9806
Bethesda, MD - 20892-9806

National Institute of Allergy and Infectious Diseases (NIAID) News

New antibody discovery may lead to effective Ebola treatment

Friday, Mar 11, 2016 @ 6:37pm by BioPrepWatch Reports

A newly discovered monoclonal antibody has been tested against the human Ebola virus in primates and has proven to protect primates against the Ebola virus, even up to five days after the initial infection.
Read More »

Vaccine developed to beat dengue fever faces clinical trial

Saturday, Jan 16, 2016 @ 9:35am by BioPrepWatch Reports

Researchers in Brazil are launching a clinical trial for a vaccine they believe can prevent dengue fever, a potentially fatal disease transmitted by mosquitoes.
Read More »

Malaria treatments ineffective against drug-resistant parasites in Cambodia

Monday, Jan 11, 2016 @ 4:26pm by BioPrepWatch Reports

Researchers from the NIAID, a branch of the NIH, found that the first-line malaria treatment being used in Cambodia is ineffective because the parasites have developed resistance.
Read More »

Nanopore sequencing could aid outbreak efforts in remote areas

Wednesday, Dec 23, 2015 @ 4:15pm by BioPrepWatch Reports

A team of researchers recently detailed the sequencing capabilities of the nanopore sequencer as a tool for remote areas affected by an outbreak.
Read More »

Study of malaria diagnostics during Ebola outbreak suggests feasibility

Wednesday, Dec 9, 2015 @ 8:30am by BioPrepWatch Reports

The U.S. Centers for Disease Control and Prevention (CDC) has released a study that evaluated the feasibility of carrying out malaria diagnostics during an outbreak of Ebola in the Emerging Infectious Disease journal.
Read More »

Registration opens for PHEMCE 2016 Stakeholders Workshop

Thursday, Dec 3, 2015 @ 2:26pm by BioPrepWatch Reports

The Public Health Emergency Medical Countermeasures Enterprise has announced that registration for its Stakeholders Workshop closes Friday, Dec. 11.
Read More »

NIH initiates chikungunya vaccine trial

Saturday, Nov 28, 2015 @ 12:25pm by BioPrepWatch Reports

NIH opened a clinical trial for a vaccine candidate against the chikungunya virus this week.
Read More »

NIH study indicates Ebola's ability to persist in semen

Sunday, Nov 22, 2015 @ 4:58pm by BioPrepWatch Reports

The Centers for Disease Control and Prevention’s (CDC) Emerging Infectious Diseases released a recent study that indicates that the Ebola virus persists after infection in certain bodily fluids.
Read More »

Study shows vaccine candidate targets key malaria protein

Wednesday, Sep 23, 2015 @ 7:09pm by BioPrepWatch Reports

The National Institute of Allergy and Infectious Diseases (NIAID) released a report Friday that detailed a study of the RTS,S vaccine that is in clinical testing against malaria. The vaccine candidate targets the circumsporozoite protein (CSP) that the parasite releases as it enters a host, primarily by mosquito bite.
Read More »

Human trial for Ebola drug ZMapp begins in Liberia

Friday, Feb 27, 2015 @ 5:36pm by BioPrepWatch Reports

A human safety and efficacy trial for an experimental Ebola virus drug treatment opened on Friday in Liberia.  The drug, ZMapp, was developed by Mapp Biopharmaceutical and utilizes monoclonal antibodies to neutralize progression of the disease and deactivate the virus.
Read More »

Ebola trial in Liberia seeks volunteers

Tuesday, Feb 3, 2015 @ 4:50pm by BioPrepWatch Reports

A large-scale Ebola vaccine trial is seeking volunteers for two experimental vaccines in Liberia, the National Institutes of Health (NIH) reported Monday.
Read More »

Ugandan trial of early-generation Ebola vaccine promising

Tuesday, Jan 6, 2015 @ 2:35pm by BioPrepWatch Reports

Results from early-stage testing of two Ebola and Marburg Virus vaccines in Uganda are promising.
Read More »

Enanta to end non-biodefense antibiotics program

Friday, Dec 12, 2014 @ 5:19pm by BioPrepWatch Reports

Enanta Pharmaceuticals said Thursday that it will discontinue development of its antibiotic program for non-biodefense indicators.
Read More »

NIH supports development of Ebola vaccine

Thursday, Oct 16, 2014 @ 3:50pm by BioPrepWatch Reports

The National Institute of Allergy and Infectious Disease (NIAID), a division of the National Institutes of Health (NIH) is sponsoring a research project to develop a vaccine to prevent rabies and Ebola.
Read More »